policy
Adverse event reporting
The AVMA encourages veterinarians to report adverse events, and encourages continued development and strengthening of adverse event reporting systems.
policy
Development of emerging disease agent biologics
Development of emerging infectious disease biologics is essential for One Health. The AVMA supports the development of these products through…
policy
UNDER REVIEWExtractive industries
AVMA supports objective scientific research on extractive industries' impacts on animal health, foods of animal and plant origin, and the environment.
policy
Guidelines for use of autogenous biologics
Autogenous biological products may provide veterinarians a unique opportunity for control of certain infectious diseases when USDA-licensed commercial…
policy
National Animal Health Laboratory Network (NAHLN) funding
The AVMA advocates for funding to develop and maintain infrastructure for a comprehensive National Animal Health Laboratory Network so that the U.S.…